These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7948107)
1. Posttranslational regulation of p53 tumor suppressor protein function. Maxwell SA; Roth JA Crit Rev Oncog; 1994; 5(1):23-57. PubMed ID: 7948107 [TBL] [Abstract][Full Text] [Related]
2. Signaling to p53: breaking the posttranslational modification code. Appella E; Anderson CW Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956 [TBL] [Abstract][Full Text] [Related]
3. The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells. Weiss RH; Randour CJ Cell Signal; 2000 Jun; 12(6):413-8. PubMed ID: 10889470 [TBL] [Abstract][Full Text] [Related]
4. Evidence for allosteric effects on p53 oligomerization induced by phosphorylation. Muller P; Chan JM; Simoncik O; Fojta M; Lane DP; Hupp T; Vojtesek B Protein Sci; 2018 Feb; 27(2):523-530. PubMed ID: 29124793 [TBL] [Abstract][Full Text] [Related]
5. Redox modulation of p53: mechanisms and functional significance. Kim DH; Kundu JK; Surh YJ Mol Carcinog; 2011 Apr; 50(4):222-34. PubMed ID: 21465572 [TBL] [Abstract][Full Text] [Related]
6. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation. Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840 [TBL] [Abstract][Full Text] [Related]
7. Posttranslational phosphorylation of mutant p53 protein in tumor development. Matsumoto M; Furihata M; Ohtsuki Y Med Mol Morphol; 2006 Jun; 39(2):79-87. PubMed ID: 16821145 [TBL] [Abstract][Full Text] [Related]
8. A cellular protein activates the sequence-specific DNA-binding of p53 by interacting with the central conserved region. Srinivasan R; Maxwell SA Oncogene; 1996 Jan; 12(1):193-200. PubMed ID: 8552392 [TBL] [Abstract][Full Text] [Related]
9. Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53. Leiter LM; Chen J; Marathe T; Tanaka M; Dutta A Oncogene; 1996 Jun; 12(12):2661-8. PubMed ID: 8700525 [TBL] [Abstract][Full Text] [Related]
10. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants. Inga A; Resnick MA Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991 [TBL] [Abstract][Full Text] [Related]
11. Cell cycle regulation and the p53 tumor suppressor protein. Mercer WE Crit Rev Eukaryot Gene Expr; 1992; 2(3):251-63. PubMed ID: 1511188 [TBL] [Abstract][Full Text] [Related]
12. Binding of cellular proteins to a conformational domain of tumor suppressor protein p53. Maxwell SA; Roth JA Oncogene; 1993 Dec; 8(12):3421-6. PubMed ID: 8247546 [TBL] [Abstract][Full Text] [Related]